Alector, GSK Team Up to Develop 2 Antibody Treatments for ALS,

AL001, on the other hand, is already in clinical trials for FTD patients and is expected to enter a Phase 2 clinical trial for ALS later this year. “Our focus …, AL001, on the other hand, is already in clinical trials for FTD patients and is expected to enter a Phase 2 clinical trial for ALS later this year. “Our focus …, Read More

Scroll to Top